For: | Liem MS, Poon RT, Lo CM, Tso WK, Fan ST. Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol 2005; 11(29): 4465-4471 [PMID: 16052673 DOI: 10.3748/wjg.v11.i29.4465] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i29/4465.htm |
Number | Citing Articles |
1 |
Saleh Daher, Muhammad Massarwa, Ariel A. Benson, Tawfik Khoury. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. Journal of Clinical and Translational Hepatology 2018; 6(1): 1 doi: 10.14218/JCTH.2017.00031
|
2 |
Omar Elshaarawy, Alzhraa Alkhatib, Mostafa Elhelbawy, Asmaa Gomaa, Naglaa Allam, Ayman Alsebaey, Eman Rewisha, Imam Waked. Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma. World Journal of Hepatology 2019; 11(6): 542-552 doi: 10.4254/wjh.v11.i6.542
|
3 |
Hiroshi Igaki, Keiichi Nakagawa, Kenshiro Shiraishi, Shuichiro Shiina, Norihiro Kokudo, Atsuro Terahara, Hideomi Yamashita, Nakashi Sasano, Masao Omata, Kuni Ohtomo. Three-dimensional Conformal Radiotherapy for Hepatocellular Carcinoma with Inferior Vena Cava Invasion. Japanese Journal of Clinical Oncology 2008; 38(6): 438 doi: 10.1093/jjco/hyn038
|
4 |
Min Jae Yang, So Yun An, Eun Joon Moon, Min Suk Lee, Joo An Hwang, Jae Youn Cheong, Je Hwan Won, Jai Keun Kim, Hee Jung Wang, Sung Won Cho. Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm. The Korean Journal of Hepatology 2009; 15(4): 474 doi: 10.3350/kjhep.2009.15.4.474
|
5 |
Peter Gunvén. Liver embolizations in oncology: A review. Medical Oncology 2008; 25(1): 1 doi: 10.1007/s12032-007-0039-3
|
6 |
Jong Won Choi, Jun Yong Park, Sang Hoon Ahn, Ki Tae Yoon, Heung-kyu Ko, Do Yun Lee, Jong Tae Lee, Kyung Sik Kim, Jin Sub Choi, Kwang-Hyub Han, Chae Yoon Chon, Do Young Kim. Efficacy and Safety of Transarterial Chemoembolization in Recurrent Hepatocellular Carcinoma After Curative Surgical Resection. American Journal of Clinical Oncology 2009; 32(6): 564 doi: 10.1097/COC.0b013e3181967da0
|
7 |
Lei Li, Jiangke Tian, Peng Liu, Xuan Wang, Zhenyu Zhu. Transarterial Chemoembolization Combination Therapy vs Monotherapy in Unresectable Hepatocellular Carcinoma: A Meta-Analysis. Tumori Journal 2016; 102(3): 301 doi: 10.5301/tj.5000491
|
8 |
Sanjay Gupta, Kenneth C. Wright, Joe Ensor, Carolyn S. Van Pelt, Katherine A. Dixon, Vikas Kundra. Hepatic Arterial Embolization with Doxorubicin-Loaded Superabsorbent Polymer Microspheres in a Rabbit Liver Tumor Model. CardioVascular and Interventional Radiology 2011; 34(5): 1021 doi: 10.1007/s00270-011-0154-6
|
9 |
Hiroyuki Kirikoshi, Satoru Saito, Masato Yoneda, Koji Fujita, Hironori Mawatari, Takashi Uchiyama, Takuma Higurashi, Ayumu Goto, Hirokazu Takahashi, Yasunobu Abe, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Takashi Sakaguchi, Norio Ueno, Atsushi Nakajima. Outcome of transarterial chemoembolization monotherapy, and in combination with percutaneous ethanol injection, or radiofrequency ablation therapy for hepatocellular carcinoma. Hepatology Research 2009; 39(6): 553 doi: 10.1111/j.1872-034X.2009.00490.x
|
10 |
Stuart K. Roberts, Alessia Gazzola, John Lubel, Paul Gow, Sally Bell, Amanda Nicoll, Anouk Dev, Michael A. Fink, Siddharth Sood, Virginia Knight, Thai Hong, Eldho Paul, Gauri Mishra, Ammar Majeed, William Kemp. Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival. Scandinavian Journal of Gastroenterology 2018; 53(10-11): 1368 doi: 10.1080/00365521.2018.1517277
|
11 |
Daniel B. Brown, William C. Chapman, Ryan D. Cook, Jason R. Kerr, Jennifer E. Gould, Thomas K. Pilgram, Michael D. Darcy. Chemoembolization of Hepatocellular Carcinoma: Patient Status at Presentation and Outcome over 15 Years at a Single Center. American Journal of Roentgenology 2008; 190(3): 608 doi: 10.2214/AJR.07.2879
|
12 |
Weng Ng, Susannah Jacob, Geoff Delaney, Viet Do, Michael Barton. Estimation of an Optimal Chemotherapy Utilisation Rate for Upper Gastrointestinal Cancers: Setting an Evidence-Based Benchmark for the Best-Quality Cancer Care. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/753480
|
13 |
Roberto Miraglia, Giada Pietrosi, Luigi Maruzzelli, Ioannis Petridis, Settimo Caruso, Gianluca Marrone, Giuseppe Mamone, Giovanni Vizzini, Angelo Luca, Bruno Gridelli. Predictive factors of tumor response to trans-catheter treatment in cirrhotic patients with hepatocellular carcinoma: A multivariate analysis of pre-treatment findings. World Journal of Gastroenterology 2007; 13(45): 6022-6026 doi: 10.3748/wjg.v13.i45.6022
Abstract(786) |
Core Tip(679) |
Full Article(HTML)(1398)
|
Full Article (PDF)-665K(715)
|
Times Cited (0)
|
Total Visits (3959)
|
Open
|
14 |
Jong Woo Kim, Jin Hyoung Kim, Kyu-Bo Sung, Heung-Kyu Ko, Ji Hoon Shin, Pyo Nyun Kim, Hyun-Kyung Choi, Gi-Young Ko, Hyun-Ki Yoon, Seng-Yong Chun, Dong Il Gwon. Transarterial Chemoembolization vs. Radiofrequency Ablation for the Treatment of Single Hepatocellular Carcinoma 2 cm or Smaller. American Journal of Gastroenterology 2014; 109(8): 1234 doi: 10.1038/ajg.2014.152
|
15 |
Siobhán McGrane, Sean E. McSweeney, Michael. M. Maher. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdominal Imaging 2008; 33(1): 48 doi: 10.1007/s00261-007-9313-2
|
16 |
Giada Pietrosi, Roberto Miraglia, Angelo Luca, Giovanni Battista Vizzini, Daniela Fili', Volpes Riccardo, Adele D'Antoni, Ioannis Petridis, Luigi Maruzzelli, Domenico Biondo, Bruno Gridelli. Arterial Chemoembolization/Embolization and Early Complications after Hepatocellular Carcinoma Treatment: A Safe Standardized Protocol in Selected Patients with Child Class A and B Cirrhosis. Journal of Vascular and Interventional Radiology 2009; 20(7): 896 doi: 10.1016/j.jvir.2009.03.032
|
17 |
D. Y. Kim, H. J. Ryu, J. Y. Choi, J. Y. Park, D. Y. Lee, B. K. Kim, S. U. Kim, S. H. Ahn, C. Y. Chon, K.‐H. Han. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2012; 35(11): 1343 doi: 10.1111/j.1365-2036.2012.05089.x
|
18 |
Suk Kyeong Ji, Yun Ku Cho, Yong Sik Ahn, Mi Young Kim, Yoon Ok Park, Jae Kyun Kim, Wan Tae Kim. Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on uperselective Chemoembolization. Korean Journal of Radiology 2008; 9(6): 534 doi: 10.3348/kjr.2008.9.6.534
|
19 |
Asmaa I Gomaa, Alzhraa Al-Khatib, Wael Abdel-Razek, Mohammed Saad Hashim, Imam Waked. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. World Journal of Gastroenterology 2015; 21(18): 5654-5662 doi: 10.3748/wjg.v21.i18.5654
|
20 |
Laura Marelli, Rosa Stigliano, Christos Triantos, Marco Senzolo, Evangelos Cholongitas, Neil Davies, Jonathan Tibballs, Tim Meyer, David W. Patch, Andrew K. Burroughs. Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies. CardioVascular and Interventional Radiology 2007; 30(1): 6 doi: 10.1007/s00270-006-0062-3
|
21 |
Rong‐xin Chen, Yu‐hong Gan, Ning‐lin Ge, Yi Chen, Hui Ma, Yan Wang, Bo‐heng Zhang, Yan‐hong Wang, Sheng‐long Ye, Jian‐feng Luo, Zheng‐gang Ren. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching. Journal of Gastroenterology and Hepatology 2016; 31(2): 442 doi: 10.1111/jgh.13077
|
22 |
Katerina Malagari, Efthimia Alexopoulou, Katerina Chatzimichail, Brenda Hall, John Koskinas, Samantha Ryan, Eva Gallardo, Alexis Kelekis, Athanassios Gouliamos, Dimitrios Kelekis. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdominal Imaging 2008; 33(5): 512 doi: 10.1007/s00261-007-9334-x
|
23 |
Sanjay Gupta, Satoshi Kobayashi, Sith Phongkitkarun, Lyle D. Broemeling, Zuxing Kan. Effect of Transcatheter Hepatic Arterial Embolization on Angiogenesis in an Animal Model. Investigative Radiology 2006; 41(6): 516 doi: 10.1097/01.rli.0000209663.00629.8a
|
24 |
R. López-Benítez, B.A. Radeleff, H.M. Barragán-Campos, G. Noeldge, L. Grenacher, G.M. Richter, P. Sauer, M. Büchler, G. Kauffmann, P.J. Hallscheidt. Acute Pancreatitis after Embolization of Liver Tumors: Frequency and Associated Risk Factors. Pancreatology 2007; 7(1): 53 doi: 10.1159/000101878
|
25 |
Thuong G. Van Ha. Difficult Decisions in Hepatobiliary and Pancreatic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach 2016; : 139 doi: 10.1007/978-3-319-27365-5_12
|